C
Vertex, Inc. VERX
$34.96 -$0.59-1.66%
Recommendation
Hold
Prev Close
$35.55
Volume
44,467
Avg Vol (90D)
1,181,177
Market Cap
$5.62B
Dividend & Yield
--
52-Week Range
$27.22 - $60.71
P/E (TTM)
--
EPS (TTM)
-$0.3407
My Lists My Alerts
Rating
Reward
B
Good
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Fair
Solvency Index
Excellent
Total Return Index
Good
Volatility Index
Fair
Dividend Index
--
Headlines
Jim Cramer on Vertex Pharmaceuticals (VRTX): Revolutionary Pain Drug on the Horizon!
3/31/2025 - Yahoo! Finance: News
Vertex Pharmaceuticals price target raised to $567 from $555 at BofA
3/31/2025 - TipRanks Financial Blog
Vertex Pharmaceuticals price target raised by $12 at BofA, here's why
3/31/2025 - The Fly
Clearbridge Investments LLC Has $745.34 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
3/31/2025 - MarketBeat
California Public Employees Retirement System Decreases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
3/31/2025 - MarketBeat
Allstate Corp Makes New $3.07 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
3/31/2025 - MarketBeat
vertex abandons islet cell device combo after it failed improve diabetes biomarker
3/31/2025 - FierceBiotech.com - Biotech
Best Biotech Stocks To Keep An Eye On - March 30th
3/30/2025 - MarketBeat
Alphabet Inc. (GOOGL)'s AI Powers Lockheed Martin's National Security Innovations
3/30/2025 - Insider Monkey
Allianz SE Invests $9.59 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
3/30/2025 - MarketBeat
Is EPAM Systems, Inc. (EPAM) the Best Mid Cap AI Stock to Buy Now?
3/29/2025 - Insider Monkey
Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price
3/29/2025 - Simply Wall St
Best Biotech Stocks To Follow Today - March 29th
3/29/2025 - MarketBeat
Vertex: More Appealing At A Lower Price, But Don't Rush In (Rating Upgrade)
3/29/2025 - SeekingAlpha
Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?
3/28/2025 - Insider Monkey
Vertex Pharmaceuticals (VRTX) Halts VX-264 Development, Incurs $400M Impairment
3/28/2025 - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know
3/28/2025 - Zacks Investment Research
Vertex Announces Program Updates for Type 1 Diabetes Portfolio
3/28/2025 - GuruFocus
Vertex to take $400M impairment charge as it abandons diabetes drug program
3/28/2025 - SeekingAlpha.com: All News
Vertex to take $400M impairment charge as it abandons diabetes drug program
3/28/2025 - Seeking Alpha - Healthcare
Vertex Pharmaceuticals pursuing research-stage T1Dd programs
3/28/2025 - TipRanks Financial Blog
Vertex Pharmaceuticals pursuing research-stage T1Dd programs
3/28/2025 - The Fly
Vertex Pharmaceuticals says VX-264 study did not meet primary endpoint
3/28/2025 - TipRanks Financial Blog
Vertex Pharmaceuticals says VX-264 study did not meet primary endpoint
3/28/2025 - The Fly
Promising Biotech Stocks To Watch Now - March 28th
3/28/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$666.78M
EBITDA (TTM)
$26.02M
EBIT (TTM)
$18.84M
Net Income (TTM)
-$52.73M
Balance Sheet
Total Assets (Q)
$1.17B
Total Debt (Q)
$351.89M
Total Liabilities (Q)
$987.44M
Book Value Per Share (Q)
$1.14
Cash Flow
Cash from Operations (TTM)
$164.82M
Cash from Investing (TTM)
-$158.15M
Cash from Financing (TTM)
$231.26M
Net Change in Cash (TTM)
$236.92M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.32
7-Day Total Return
-3.32%
30-Day Total Return
-24.83%
60-Day Total Return
-34.47%
90-Day Total Return
-28.80%
Year to Date Total Return
-34.29%
1-Year Total Return
9.15%
2-Year Total Return
77.55%
3-Year Total Return
133.38%
5-Year Total Return
--
52-week Low
Apr 23, 2024 - $27.22
52-week High
Feb 06, 2025 - $60.71
Valuation
Market Cap
$5.62B - Mid Cap
Enterprise Value
$5.67B
Price/Sales (TTM)
8.33
Price/Book (Q)
31.15
Dividends and Shares
Shares Outstanding
156.26M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vertexinc.com
Phone Number
800 355 3500
Address
2301 Renaissance Boulevard
King of Prussia, PA 19406
Country
United States
Year Founded
1978
Business Description
Sector
Information Technology
Industry
Software and Services
Vertex, Inc., together with its subsidiaries, provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and... more
NASDAQ 03/31/2025 9:37AM Eastern Quotes delayed
Weiss Ratings